934 results on '"Milano, Filippo"'
Search Results
2. Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
3. Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies
4. Combining distribution modelling and phylogeography to understand present, past and future of an endangered spider
5. Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia
6. Corrigendum
7. CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
8. Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
9. Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
10. Old but not obsolete: Dimensional analysis in nondestructive testing and evaluation
11. Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
12. γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
13. Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors
14. Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
15. Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients
16. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML
17. Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.
18. A first-in-human phase 1, multicenter, open-label study of CB-012, a next-generation CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy for adults with relapsed/refractory acute myeloid leukemia (AMpLify).
19. Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
20. Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients
21. Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation
22. Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia
23. Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis
24. Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
25. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
26. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience
27. Cord blood maternal microchimerism following unrelated cord blood transplantation
28. Forensic Characterisation of Complex Suicides: A Literature Review.
29. Post-mortem tetramorphism: Four morphological changes within the same corpse.
30. Guidelines for Cord Blood Unit Selection
31. Guidelines for Cord Blood Unit Thaw and Infusion
32. Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study
33. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
34. Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation
35. Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML
36. Early Prediction of Severe Icans after CD19 CAR T-Cell Therapy Based on Serum Ferritin Levels
37. Second Allogeneic Hematopoietic Cell Transplantation for Relapse in Adults with Acute Myeloid Leukemia: Outcomes and Prognostic Factors
38. Safety and Efficacy of Fully-Human-Binder-Bearing CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma after Failure of Murine-Binder-Bearing CD19 CAR T-Cell Therapy
39. Identification and Prediction of Severe Hematologic Toxicity after CAR T-Cell Therapy Using Machine Learning-Based Time-Series Clustering
40. Identification of Predictors of CRS and Neurotoxicity Duration after Axicabtagene Ciloleucel Therapy
41. Planned Interim Analysis of a Phase 2 Investigator-Initiated Trial of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene Maraleucel
42. Real-World Comparison of Lisocabtagene Maraleucel (Liso-Cel) and Axicabtagene Ciloleucel (Axi-Cel): Efficacy & Toxicity
43. T-Cell Large Granular Lymphocyte Population Involving Chimeric Antigen Receptor-Modified T (CAR T) Cells in Patients with Cytopenia after CD19-Targeted CAR T-Cell Therapy: Case Series
44. BLE-Based Indoor Localization: Analysis of Some Solutions for Performance Improvement
45. Taxonomy, ecology and conservation of the cave-dwelling spider Histopona palaeolithica , with the description of H. petrovi sp. nov. (Araneae: Agelenidae)
46. Alternative Sources of Hematopoietic Stem Cells and Their Clinical Applications
47. Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy
48. Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources
49. Application of dimensional analysis to ECT in the era of NDE 4.0.
50. Lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma: feasibility, safety and efficacy in a real-world setting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.